January 1, 2010Blood Purification
Special Considerations for Antihypertensive Agents in Dialysis Patients
Population
Patients with end-stage renal disease on chronic dialysis with hypertension
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support RAAS-based regimens in dialysis hypertension; leaves open prospective RCTs to confirm cardioprotection beyond BP control.
Structured PICO
P
Population
Patients with end-stage renal disease on chronic dialysis with hypertension
I
Intervention
Antihypertensive agents (specifically drugs acting on the renin-angiotensin-aldosterone system, sympathetic tone, and calcium influx)
Antihypertensive therapy in dialysis patients requires careful consideration of altered pharmacokinetics and should prioritize agents targeting RAAS, sympathetic tone, and calcium channels.
Cite This Study
Redón et al. (2010) studied this question.